文献速递乳腺癌放疗

一项关于1072例接受保乳手术和全乳放疗的DCIS患者的全国多中心研究(COBCG-01研究)

A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
PubMed 文献 · Radiother Oncol · 2018-07-31

该回顾性多中心分析纳入意大利9个中心1997至2012年治疗的1072例接受保乳手术加全乳放疗的导管原位癌(DCIS)患者,中位随访8.4年,5年和10年局部复发率分别为3.4%和7.6%,乳腺癌特异性生存率分别为99.7%和99.1%。多因素分析显示绝经后状态和雌激素受体(ER)阳性与局部复发呈独立负相关,最终手术切缘(FSM)<1 mm与局部复发风险升高显著相关。

要点

  • 中位随访8.4年,1072例DCIS患者共观察到67例局部复发(6.3%)和47例死亡(4.4%)。
  • 5年和10年局部复发率分别为3.4%和7.6%,乳腺癌特异性生存率分别为99.7%和99.1%。
  • 多因素分析显示绝经后状态(p=0.03)和ER阳性(p=0.045)与局部复发呈独立负相关,FSM<1 mm(p=0.024)与局部复发风险升高独立相关。

核心结论

  • 该真实世界研究指出绝经后状态和ER阳性状态对局部复发具有显著的有利预后作用。
  • FSM<1 mm与局部复发风险升高显著相关。

研究设计与样本

  • 回顾性多中心分析,纳入意大利9个中心1997至2012年间诊断并治疗的1072例DCIS女性患者,均接受保乳手术和辅助放疗。
  • 采用Kaplan-Meier法报告5年和10年局部复发率、总生存率和乳腺癌特异性生存率。

主要发现

  • 中位随访8.4年,共观察到67例局部复发(6.3%)和47例死亡(4.4%)。
  • 5年和10年局部复发率分别为3.4%和7.6%。
  • 5年和10年乳腺癌特异性生存率分别为99.7%和99.1%。
  • 单因素回归分析中,绝经后状态(p=0.009)、ER阳性(p=0.0001)、孕激素受体阳性(p=0.018)和内分泌治疗(p=0.006)与局部复发呈负相关,FSM<1 mm与局部复发升高显著相关(p=0.003)。
  • 多因素回归分析中,绝经后状态(p=0.03)和ER阳性(p=0.045)保持显著有利特征,FSM<1 mm(p=0.024)确认其对局部复发的负面影响。

关键数值与推荐

  • 单因素分析:绝经后状态p=0.009、ER阳性p=0.0001、孕激素受体阳性p=0.018、内分泌治疗p=0.006均与局部复发呈负相关;FSM<1 mm与局部复发升高显著相关(p=0.003)。
  • 多因素分析:绝经后状态p=0.03、ER阳性p=0.045为显著有利因素;FSM<1 mm p=0.024为显著不利因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT. MATERIALS AND METHODS: We collected clinical data from nine Italian centers on 1072 women having a diagnosis of DCIS and treated between 1997 and 2012. We reported on the 5- and 10-year local recurrence (LR) rates, overall survival, and breast cancer specific survival (BCSS) employing the Kaplan-Meier method. RESULTS: At a median follow-up of 8.4 years, 67 LR (6.3%) and 47 deaths (4.4%) were observed. LR rates at 5 and 10 years were 3.4% and 7.6%, respectively. BCSS rates at 5 and 10 years were 99.7% and 99.1%, respectively. At univariate regression analysis, postmenopausal state (p = 0.009), estrogen receptor (ER) (p = 0.0001) and progesterone receptor (p = 0.018) positivity and ET (p = 0.006) were inversely correlated with LR. Final surgical margins (FSM) status <1 mm was significantly correlated with higher LR (p = 0.003). At multivariate regression analysis postmenopausal state (p = 0.03), and ER positive (p = 0.045) maintained the significant favorable feature, while FSM <1 mm (p = 0.024) confirmed its negative impact on LR. CONCLUSIONS: Our real-life study pointed out the significant favorable prognostic role of postmenopausal state and ER positive status on LR occurrence. FSM <1 mm was significantly correlated to a higher chance to experience LR.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Meattini I, Pasinetti N, Meduri B, et al. A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study). Radiother Oncol. 2018. PMID: 30075864. doi:10.1016/j.radonc.2018.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。